Taurine improves neuron injuries and cognitive impairment in a mouse Parkinson’s disease model through inhibition of microglial activation

Aarsland, 2010, The epidemiology of dementia associated with Parkinson’s disease, Brain pathol. (Zurich, Switzerland), 20, 633, 10.1111/j.1750-3639.2009.00369.x Aarsland, 2003, Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study, Arch. Neurol., 60, 387, 10.1001/archneur.60.3.387 Aldieri, 2008, Classical inhibitors of NOX NAD(P)H oxidases are not specific, Curr. Drug Metab., 9, 686, 10.2174/138920008786049285 Belarbi, 2017, NADPH oxidases in Parkinson’s disease: a systematic review, Mol. Neurodegener., 12, 84, 10.1186/s13024-017-0225-5 Benoy, 2018, Hippocampal area CA2: an emerging modulatory gateway in the hippocampal circuit, Exp. Brain Res., 236, 919, 10.1007/s00221-018-5187-5 Brown, 2009, Nox proteins in signal transduction, Free Radic. Biol. Med., 47, 1239, 10.1016/j.freeradbiomed.2009.07.023 Brown, 2020, Supplemental taurine during adolescence and early adulthood has sex-specific effects on cognition, behavior and neurotransmitter levels in C57BL/6J mice dependent on exposure window, Neurotoxicol. Teratol., 79, 10.1016/j.ntt.2020.106883 Canton, 2013, Scavenger receptors in homeostasis and immunity, Nat. Rev. Immunol., 13, 621, 10.1038/nri3515 Che, 2018, Taurine protects dopaminergic neurons in a mouse Parkinson’s disease model through inhibition of microglial M1 polarization, Cell Death Dis., 9, 435, 10.1038/s41419-018-0468-2 Chen, 2010, The toxic influence of paraquat on hippocampus of mice: involvement of oxidative stress, Neurotoxicology, 31, 310, 10.1016/j.neuro.2010.02.006 Chen, 2019, Roles of taurine in cognitive function of physiology, pathologies and toxication, Life Sci., 231, 10.1016/j.lfs.2019.116584 Coley, 2018, PSD95: a synaptic protein implicated in schizophrenia or autism?, Prog. Neuropsychopharmacol. Biol. Psychiatry, 82, 187, 10.1016/j.pnpbp.2017.11.016 Cooper, 2018, On the run for hippocampal plasticity, Cold Spring Harb. Perspect. Med., 8, 10.1101/cshperspect.a029736 Das, 2018, Intranasally delivered small interfering RNA-mediated suppression of scavenger receptor Mac-1 attenuates microglial phenotype switching and working memory impairment following hypoxia, Neuropharmacology, 137, 240, 10.1016/j.neuropharm.2018.05.002 Ding, 2020, Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson’s disease, Toxicology, 436, 10.1016/j.tox.2020.152437 Doorn, 2012, Emerging roles of microglial activation and non-motor symptoms in Parkinson’s disease, Prog. Neurobiol., 98, 222, 10.1016/j.pneurobio.2012.06.005 Duan, 2016, Novel insights into NeuN: from neuronal marker to splicing regulator, Mol. Neurobiol., 53, 1637, 10.1007/s12035-015-9122-5 Femminella, 2016, Does microglial activation influence hippocampal volume and neuronal function in Alzheimer’s disease and Parkinson’s disease dementia?, J. Alzheimer’s Dis. JAD, 51, 1275, 10.3233/JAD-150827 Foltynie, 2004, The cognitive ability of an incident cohort of Parkinson’s patients in the UK. The CamPaIGN study, Brain, 127, 550, 10.1093/brain/awh067 Franke, 2017, Nonmotor fluctuations in Parkinson’s disease, Int. Rev. Neurobiol., 134, 947, 10.1016/bs.irn.2017.05.021 GBD 2016 Parkinson’s Disease Collaborators, 2018, Global, regional, and national burden of Parkinson’s disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, Lancet Neurol Hall, 2014, Hippocampal Lewy pathology and cholinergic dysfunction are associated with dementia in Parkinson’s disease, Brain, 137, 2493, 10.1093/brain/awu193 Hou, 2017, Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation, Toxicology, 380, 1, 10.1016/j.tox.2017.02.009 Hou, 2018, Taurine protects noradrenergic locus coeruleus neurons in a mouse Parkinson’s disease model by inhibiting microglial M1 polarization, Amino Acids, 50, 547, 10.1007/s00726-018-2547-1 Hou, 2018, Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway, Redox Biol., 14, 250, 10.1016/j.redox.2017.09.017 Hou, 2019, Inhibition of NADPH oxidase by apocynin prevents learning and memory deficits in a mouse Parkinson’s disease model, Redox Biol., 22, 10.1016/j.redox.2019.101134 Jakaria, 2019, Taurine and its analogs in neurological disorders: focus on therapeutic potential and molecular mechanisms, Redox Biol., 24, 10.1016/j.redox.2019.101223 Keating, 2009, Losartan/Hydrochlorothiazide: a review of its use in the treatment of hypertension and for stroke risk reduction in patients with hypertension and left ventricular hypertrophy, Drugs, 69, 1239, 10.2165/00003495-200969090-00008 Khan, 2019, 17beta-estradiol modulates SIRT1 and halts oxidative stress-mediated cognitive impairment in a male aging mouse model, Cells, 8, 10.3390/cells8080928 Kumari, 2013, Taurine and its neuroprotective role, Adv. Exp. Med. Biol., 775, 19, 10.1007/978-1-4614-6130-2_2 Li, 2016, Developmental exposure to paraquat and maneb can impair cognition, learning and memory in Sprague-Dawley rats, Mol. Biosyst., 12, 3088, 10.1039/C6MB00284F Litteljohn, 2011, The effects of paraquat on regional brain neurotransmitter activity, hippocampal BDNF and behavioural function in female mice, Neurosci. Lett., 502, 186, 10.1016/j.neulet.2011.07.041 Lossi, 2018, Caspase-3 mediated cell death in the normal development of the mammalian cerebellum, Int. J. Mol. Sci., 19, 10.3390/ijms19123999 Ma, 2017, Physical exercise induces hippocampal neurogenesis and prevents cognitive decline, Behav. Brain Res., 317, 332, 10.1016/j.bbr.2016.09.067 Ma, 2017, NADPH oxidase in brain injury and neurodegenerative disorders, Mol. Neurodegener., 12, 7, 10.1186/s13024-017-0150-7 McDowell, 2012, Animal models of the non-motor features of Parkinson’s disease, Neurobiol. Dis., 46, 597, 10.1016/j.nbd.2011.12.040 Muslimovic, 2005, Cognitive profile of patients with newly diagnosed Parkinson disease, Neurology, 65, 1239, 10.1212/01.wnl.0000180516.69442.95 Nakahara, 2018, Hippocampal pathophysiology: commonality shared by temporal lobe epilepsy and psychiatric disorders, Neurosci. J., 2018, 10.1155/2018/4852359 Pang, 2019, Ammon’s Horn 2 (CA2) of the hippocampus: a long-known region with a new potential role in neurodegeneration, Neuroscientist, 25, 167, 10.1177/1073858418778747 PrabhuDas, 2017, A consensus definitive classification of scavenger receptors and their roles in health and disease, J. Immunol., 198, 3775, 10.4049/jimmunol.1700373 Qian, 2008, Potent anti-inflammatory and neuroprotective effects of TGF-beta1 are mediated through the inhibition of ERK and p47phox-Ser345 phosphorylation and translocation in microglia, J. Immunol., 181, 660, 10.4049/jimmunol.181.1.660 Qiu, 2016, NADPH oxidase 2-derived reactive oxygen species in the hippocampus might contribute to microglial activation in postoperative cognitive dysfunction in aged mice, Brain Behav. Immun., 51, 109, 10.1016/j.bbi.2015.08.002 Raza, 2019, Parkinson’s disease: mechanisms, translational models and management strategies, Life Sci., 226, 77, 10.1016/j.lfs.2019.03.057 Sorce, 2017, NADPH oxidases as drug targets and biomarkers in neurodegenerative diseases: what is the evidence?, Free Radic. Biol. Med., 112, 387, 10.1016/j.freeradbiomed.2017.08.006 Steel, 2008, Refining the relationship between personality and subjective well-being, Psychol. Bull., 134, 138, 10.1037/0033-2909.134.1.138 Stella, 2009, Psychopathological features in patients with Parkinson’s disease and related caregivers’ burden, Int. J. Geriatr. Psychiatry, 24, 1158, 10.1002/gps.2240 Terzi, 2020, The role of NADPH oxidases in neuronal development, Free Radic. Biol. Med., 154, 33, 10.1016/j.freeradbiomed.2020.04.027 Titova, 2017, Nonmotor symptoms in experimental models of Parkinson’s disease, Int. Rev. Neurobiol., 133, 63, 10.1016/bs.irn.2017.05.018 Tu, 2018, Preventive effects of taurine against d-galactose-induced cognitive dysfunction and brain damage, Food Funct., 9, 124, 10.1039/C7FO01210A Vorhees, 2014, Value of water mazes for assessing spatial and egocentric learning and memory in rodent basic research and regulatory studies, Neurotoxicol. Teratol., 45, 75, 10.1016/j.ntt.2014.07.003 Wang, 2014, Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase, J. Neurosci., 34, 12490, 10.1523/JNEUROSCI.2238-14.2014 Wang, 2015, Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson’s disease models, Brain, 138, 1247, 10.1093/brain/awv034 Williams-Gray, 2013, The CamPaIGN study of Parkinson’s disease: 10-year outlook in an incident population-based cohort, J. Neurol. Neurosurg. Psychiatr., 84, 1258, 10.1136/jnnp-2013-305277 Zhang, 2016, Reduced plasma taurine level in Parkinson’s disease: association with motor severity and levodopa treatment, Int. J. Neurosci., 126, 630